AdvanCell is a vertically integrated, clinical stage radiopharmaceutical company developing novel targeted alpha therapies to improve survival and the quality of life for patients with cancer

2 days ago · AdvanCell is dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides. By combining advanced manufacturing capabilities with cutting-edge ...

Feb 3, 2025 · AdvanCell致力于开发创新的癌症疗法，利用靶向α放射性核素的力量。 通过将先进制造能力与尖端科学和临床开发能力相结合，AdvanCell旨在提供新的治疗方法，以改善全球癌症患者的预后。

1 day ago · AdvanCell is dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides. By combining advanced manufacturing capabilities with cutting-edge science and clinical development capabilities, AdvanCell aims to deliver novel treatments that improve outcomes for cancer patients globally. ...

Feb 3, 2025 · AdvanCell is dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides. By combining advanced manufacturing capabilities with cutting-edge ...

1 day ago · 根据协议，AdvanCell将提供其Pb-212(铅-212)生产技术及放射性核素开发基础设施，与礼来公司的在研药物管线结合，推进一系列靶向阿尔法疗法的研发。 Pb-212是一种放射性同位素，可用于精准靶向癌细胞，减少对健康组织的损害，提高疗效的同时降低副作用。

1 day ago · AdvanCell是一家专注于放射性疗法的生物技术公司，其核心技术是阿尔法同位素发生器，该技术解决了靶向阿尔法疗法中最大的问题，即稳定且可扩展 ...

2 days ago · AdvanCell is dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides. By combining advanced manufacturing capabilities with cutting-edge science and clinical development capabilities, AdvanCell aims to deliver novel treatments that improve outcomes for cancer patients globally. ...

AdvanCell was founded on the belief that Targeted Alpha Therapies could change the course of cancer treatment and that the scalable supply of isotopes would enable the development of multiple ...

The award winning AdvanCell ²¹²Pb Generator produces a scalable supply of Alpha 212, a proprietary alpha isotope used in Targeted Alpha Therapy. HIGH-QUALITY The generator provides an unmatched, GMP compatible, manufacturing platform to support rapid clinical development of alpha radioligand therapies.